SanBio Company Limited provided earnings guidance for the Fiscal Year Ending January 31, 2023. For the full year, the company expected Operating loss of JPY 8,131 million; Net loss attributable to owners of parent to be JPY 5,684 million and net loss per share of JPY 95.36.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
775 JPY | +14.81% |
|
+58.49% | +10.40% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.40% | 338M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- 4592 Stock
- News SanBio Company Limited
- Sanbio Company Limited Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023